PHARMACEUTICS, PREFORMULATION ANDDRUG DELIVERY
- 1 May 2007
- journal article
- research article
- Published by Elsevier BV in Journal of Pharmaceutical Sciences
- Vol. 96 (5), 996-1007
- https://doi.org/10.1002/jps.20934
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Structural relationships, thermal properties, and physicochemical characterization of anhydrous and solvated crystalline forms of tetroxoprimJournal of Pharmaceutical Sciences, 2002
- Antimicrobial activities of dihydrofolate reductase inhibitors, used singly or in combination with dapsone, against Mycobacterium ulceransJournal of Antimicrobial Chemotherapy, 2001
- In vitro activity of epiroprim, a dihydrofolate reductase inhibitor, singly and in combination with brodimoprim and dapsone, against Mycobacterium lepraeInternational Journal of Antimicrobial Agents, 1999
- ORTEP-3 for Windows - a version ofORTEP-III with a Graphical User Interface (GUI)Journal of Applied Crystallography, 1997
- [20] Processing of X-ray diffraction data collected in oscillation modeMethods in Enzymology, 1997
- Correlation of trimethoprim and brodimoprim physicochemical and lipid membrane interaction properties with their accumulation in human neutrophilsAntimicrobial Agents and Chemotherapy, 1996
- Efficacy and tolerability of brodimoprim at two different dosage schedules in the treatment of acute uncomplicated bacterial cystitis: comparative study vs. pefloxacinEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1996
- Comparative Antibacterial Spectrum of Trimethoprim and BrodimoprimJournal of Chemotherapy, 1993
- Synthese von 4‐halogensubstituierten Analogen von TrimethoprimHelvetica Chimica Acta, 1977
- The crystal and molecular structure of the antifolate drug trimethoprim (2,4-diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine). A neutron diffraction studyJournal of the American Chemical Society, 1976